Patient Care ▪ Research ▪ Education

We are pleased to announce that the Temple Lung Center has completed its move into the new Ambulatory Care Center at Temple University Hospital.  Our new center fulfills our goal of integrating patient care, research and education.

One of the major objectives of the Temple Lung Center is to provide pulmonary patients and their referring physicians with access to the most advanced capabilities for disease management.  This is demonstrated by our recent expansion into a new 18,000 square foot outpatient facility.  This space was specifically designed to meet the special needs of pulmonary patients and provide them with the opportunity to participate in the cutting-edge therapies offered by clinical research trials. 

This new facility allows us to offer—in one location—office visits, routine pulmonary function and exercise testing, blood draws, electrocardiograms, sleep and non-invasive ventilator equipment instruction and titration, and pulmonary rehabilitation.

For those patients requiring evaluation or treatment for lung transplantation or other multidisciplinary medical-surgical conditions, consultations with cardiologists, surgeons and other specialists all take place at the Center. 

 

The state-of-the-art waiting room is outfitted to be a “smart classroom” for patient and family support groups, disease management lectures, and educational programs for community physicians.

 

Temple University Hospital received a Gold Seal of Approval and was named a Center of Excellence for Lung Volume Reduction Surgery (LVRS) by the Joint Commission, the nation’s top health care accrediting body.

 

CLINICAL RESEARCH TRIAL INFORMATION

Click here for more information about current clinical research trials at the Temple Lung Center. 

PA-SCOPE Pennsylvania Study of Chronic Obstructive Pulmonary Exacerations

Biologic Lung Volume Reduction (BLVR)

Do you cough or have shortness of breath?

The Temple Lung Center is conducting a clinical research study to test a new medication that may help patients with COPD to breathe easier.

You may qualify if you are:

• 44 years old or older
• Have moderate to severe COPD
• Have not smoked for at least one year
  
  

Participants receive the study-related care and up to $1025 for 15 visits over 2-1/2 years, and may have a chance to receive a new investigational drug.
To see if you qualify call 215-707-1359 and refer to study #25.

The National Institutes of Health is sponsoring a study to compare two FDA-approved vaccines for pneumonia.

You may qualify if you are:

• 40 years old or older
• A smoker or ex-smoker
• Have moderate-to-severe COPD
  
  

Participates receive vaccine (at no cost) and up to $200 for completion of all study visits (4 clinic visits and 5 phone contacts) over 24 months.